ARPC1B and familial pancreatic carcinoma: In our study, we found ARPC1B is significantly upregulated in gemcitabine‐resistant CSCs compared to non‐resistant CSCs, and it is also significantly elevated in pancreatic cancer samples versus normal tissues.